In 1974-82 this fell by 40% for spina bifida (3 0-1 8) and 36% for anencephaly (2-2-14). These findings were compared with data on birth prevalences in England and Wales, Northern Ireland, and Glasgow.
Introduction
From 1971 to 1982 the birth prevalence-the number of affected infants, born dead or alive, expressed as a proportion of all live births and stillbirths-of spina bifida and anencephaly fell substantially in Scotland. This coincided with the introduction of a widespread antenatal a fetoprotein screening programme. It was not clear whether the observed fall was wholly related to screening and termination of affected pregnancies or whether a true fall in incidence had occurred as well.
The use of the Scottish neonatal discharge record (form SMR1 1) in providing information on the incidence of congenital malformations has been discussed previously.' In the present study we extended the examination to other routine records and included information from the screening laboratories on termination of affected pregnancies. We thus examined trends in the birth prevalence of spina bifida and anencephaly in Scotland. We did not know how many fetuses in pregnancies terminated for other reasons had had anencephaly or spina bifida and therefore omitted these other terminations from both numerator and denominator. As the Abortion Act was in operation throughout the series and the numbers of abortions did not vary greatly from year to year after 1974, the number of unrecognised cases in this group was probably fairly constant. Clearly, a true incidence of anencephaly or spina bifida, reflecting the incidence of the abnormality in all conceptions, cannot be determined.
The above data indicate that from 1974 to 1982 the adjusted prevalence of spina bifida fell by 40°h whereas the birth prevalence fell by 6300; the falls in prevalences of anencephaly were 36 % and 91,0 respectively. Data for Glasgow were less consistent but mirrored the same trend. Data recently reported from the west of Scotland showed a fall in the combined adjusted birth prevalence for spina bifida and anencephaly from 5 1/1000 total births in 1976 to 4 0 in 1981 compared with from 3-9 to 3-5 in Scotland and from 4-3 to 4 0 in the Glasgow Health Board area in this period.5 The differences between Scotland as a whole and the west of Scotland (including Glasgow) were entirely consistent with the known higher prevalence of anencephaly and spina bifida in the west.4 Data on mortality and survival in babies with spina bifida (table III) showed that most deaths occurred in the calendar year of birth or in the year after, the proportion occurring in the first year ranging from 310% to 47%' . Averaged over five years the proportion of deaths occurring in the first calendar year was lower in 1978-82 than over the earlier period, but the falling number of survivors mainly reflected the substantial reduction in live births with the condition.
Discussion
A recent leading article in the British Medical Journal, commenting on trends in a number of countries,6 pointed out that defects of the neural tube seem to have become less common in Northern Ireland, the United States, and Australia as well as in England and Wales. The increase in the number of terminations in Britain and Australia was considered to be insufficient to account for the decline in these countries, and in the United States the decline started well before 1970 and before screening was available; these data may therefore reflect a true decline in the occurrence of these conditions. In the Republic of Ireland, where there is no antenatal screening programme, the decline has been negligible.
The indications from Scottish data are that both the birth prevalence of anencephaly and spina bifida and the birth prevalence adjusted for terminations have been declining during the period considered. The introduction of antenatal screening programmes has undoubtedly been instrumental in reducing the number of live births with spina bifida and the consequent burden of disability from this condition and has also resulted in a fall in cases of anencephaly; notably, in Glasgow in 1982 there was no birth with this diagnosis. (principally ultrasound) were also counted, the combined prevalence of anencephaly and spina bifida increased by 15% to 3. 1/1000 total births. Whether these other methods are used to diagnose anencephaly and spina bifida as often in Scotland, given the extensive a fetoprotein screening programme, is not known; but, if they are, a proportionate increase in the adjusted birth prevalence in 1982 would have been from 3-2 to 3-7. This is still considerably lower than the birth prevalence of anencephaly and spina bifida of 5-2 in 1974 and 1975 that we have reported here (and that must underestimate the true position) and supports other reports of a genuine fall in the incidence of anencephaly and spina bifida.
Our method of extracting information from routine data sources appears to be successful in providing data similar to that captured by a congenital malformation notification system in England and Wales. It can, in addition, provide data (for spina bifida) on subsequent death and, hence, the number of survivors; this pernmits further appraisal of the effectiveness of programmes for the prevention and treatment of this condition.
